- Home
- BFRG vs XAIR Comparison
BFRG vs XAIR Comparison
Compare BFRG & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- XAIR
- Stock Information
- Founded
- BFRG 2017
- XAIR 2011
- Country
- BFRG United States
- XAIR United States
- Employees
- BFRG N/A
- XAIR N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- XAIR Medical/Dental Instruments
- Sector
- BFRG Technology
- XAIR Health Care
- Exchange
- BFRG Nasdaq
- XAIR Nasdaq
- Market Cap
- BFRG 15.4M
- XAIR 17.0M
- IPO Year
- BFRG 2023
- XAIR N/A
- Fundamental
- Price
- BFRG $1.50
- XAIR $2.45
- Analyst Decision
- BFRG
- XAIR Strong Buy
- Analyst Count
- BFRG 0
- XAIR 1
- Target Price
- BFRG N/A
- XAIR $11.00
- AVG Volume (30 Days)
- BFRG 447.2K
- XAIR 241.3K
- Earning Date
- BFRG 11-07-2025
- XAIR 11-10-2025
- Dividend Yield
- BFRG N/A
- XAIR N/A
- EPS Growth
- BFRG N/A
- XAIR N/A
- EPS
- BFRG N/A
- XAIR N/A
- Revenue
- BFRG $33,257.00
- XAIR $4,782,000.00
- Revenue This Year
- BFRG N/A
- XAIR $261.11
- Revenue Next Year
- BFRG N/A
- XAIR $151.82
- P/E Ratio
- BFRG N/A
- XAIR N/A
- Revenue Growth
- BFRG N/A
- XAIR 168.20
- 52 Week Low
- BFRG $1.09
- XAIR $2.02
- 52 Week High
- BFRG $4.84
- XAIR $13.52
- Technical
- Relative Strength Index (RSI)
- BFRG 55.21
- XAIR 48.87
- Support Level
- BFRG $1.45
- XAIR $2.31
- Resistance Level
- BFRG $1.70
- XAIR $2.75
- Average True Range (ATR)
- BFRG 0.15
- XAIR 0.15
- MACD
- BFRG -0.00
- XAIR -0.02
- Stochastic Oscillator
- BFRG 28.79
- XAIR 25.53
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.